Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccines.
Saved in:
| Title: | Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccines. |
|---|---|
| Authors: | Ackerley CG; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, United States., Edupuganti S; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, United States., Yu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States., Roxby AC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States., Seaton KE; Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center, Durham, NC, United States., Bekker LG; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Allen M; Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States., DeRosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States., Yates NL; Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center, Durham, NC, United States., Heptinstall J; Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center, Durham, NC, United States., Mkhize NN; Setshaba Research Centre, Soshanguve, South Africa., Malahleha M; Setshaba Research Centre, Soshanguve, South Africa., Mngadi K; Aurum Institute, Tembisa Clinic 4, Ekurheleni, South Africa., Daniels B; South African Medical Research Council, Durban, South Africa., Innes C; Aurum Institute, Klerksdorp Research Centre, Klerksdorp, South Africa., Furch BD; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States., Koutsoukos M; GlaxoSmithKline (GSK) Vaccines, Rixensart, Belgium., Ferrari G; Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center, Durham, NC, United States., Morris L; National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa., Montefiori DC; Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center, Durham, NC, United States., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States., Tomaras GD; Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center, Durham, NC, United States., Laher F; Perinatal HIV Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa., Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2025 May 14; Vol. 16, pp. 1557009. Date of Electronic Publication: 2025 May 14 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1557009 |
